SLC18A2 and bipolar disorder: While HTR1A, HTR2A, and HTR7 are known targets of lurasidone, MAOB, HTR3A, SLC18A2, and HTR1B were identified for the first time as targets of lurasidone potentially involved in its associated induction of acute manic episodes in people with bipolar depression.